It was relatively recently that every Tom, Dick and Harry in the scientific community was popping vitamin E supplements in the hope that this antioxidant would help protect them from the damaging effects of free radicals.
Us elves get our vitamin E from the vegetables, fruits and whole grains that make up our naturally healthy diet. Many single studies were published in the 1990s that seemed to show that much higher doses of vitamin E (e.g. 2,000 IU/day) could help prevent major illnesses such as cancer, heart disease and stroke, as well as delaying cognitive decline and potentially preventing dementia.
An updated systematic review (with one new trial added) from the Cochrane Dementia and Cognitive Improvement Group has provided a fairly conclusive statement by saying that:
Vitamin E should not be used for the treatment of mild cognitive impairment and Alzheimer’s dementia
The reviewers searched a comprehensive range of databases, looking for unconfounded, double-blind, randomised trials in which treatment with vitamin E at any dose was compared with placebo for patients with Alzheimer’s dementia and mild cognitive impairment.
Disappointingly, they only found 3 studies that met their inclusion criteria and could be included in their analysis; two which investigated Alzheimer’s dementia and the third which looked at mild cognitive impairment.
The studies showed no or limited benefit for the use of vitamin E to prevent or treat Alzheimer’s dementia and mild cognitive impairment.
The reviewers conclude:
No convincing evidence that vitamin E is of benefit in the treatment of Alzheimer’s dementia and mild cognitive impairment. Future trials assessing vitamin E treatment in Alzheimer’s dementia should not be restricted to alpha-tocopherol.
It’s also worth noting that recent evidence has shown that high doses of vitamin E may be associated with potentially serious side-effects and even increased mortality. One such mechanism is that vitamin E diminishes the clotting tendency of blood.
Link
Farina N, Isaac MGEKN, Clark AR, Rusted J, Tabet N. Vitamin E for Alzheimer’s dementia and mild cognitive impairment. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD002854. DOI: 10.1002/14651858.CD002854.pub3.
Andre, you may find this recent JAMA study interesting, which published cancer incidence results from the The Physicians’ Health Study II, a 15,000 participant, 10+year 2x2x2x2 randomized controlled trial that looks at multivitamin use in combination with vitamin C, E and beta carotene:
http://jama.jamanetwork.com/article.aspx?articleid=1380451
According to the The PHS II website:
“Manuscripts presenting the main findings for the multivitamin component on eye disease and cognitive decline are in the final stages of completion. Please periodically check this PHS website over the coming weeks for notification that these manuscripts have been published.”
Something to look forward to. The PHS II used 400 IU of vitamin E in the form of synthetic alpha-tocopherol.
Cheers,
Brant